Press "Enter" to skip to content

Alkermes schizophrenia drug keeps weight gain side effect in check

Data from a late stage trial showed that patients on Alkermes’ drug had a mean weight gain of 4.21 percent after six months, compared with an average gain of 6.59 percent in patients receiving olanzapine, the most commonly used antipsychotic drug.

Original source: https://health.economictimes.indiatimes.com/news/pharma/alkermes-schizophrenia-drug-keeps-weight-gain-side-effect-in-check/66874579?utm_source=RSS&utm_medium=ETRSS

Also Read:   Mitsui asks Daiichi to let IHH off the hook in Singh bros Fortis case